Literature DB >> 24549622

In vitro selection of allosteric ribozymes that sense the bacterial second messenger c-di-GMP.

Kazuhiro Furukawa1, Hongzhou Gu, Ronald R Breaker.   

Abstract

Recently, a number of study have shown the ligand-dependent allosteric ribozymes can be harnessed as biosensors, high-throughput screening, and agents for the control of gene expression in vivo, called artificial riboswitches. In this chapter, we describe how in vitro selection can be used to create an allosteric ribozyme that senses bacterial second messenger cyclic-di-GMP (c-di-GMP). A hammerhead ribozyme was joined to a natural c-di-GMP class I riboswitch aptamer via communication modules. Both c-di-GMP-activating and -inhibiting ribozyme can be obtained by this approach.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549622      PMCID: PMC5325115          DOI: 10.1007/978-1-62703-755-6_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  Self-cleavage of virusoid RNA is performed by the proposed 55-nucleotide active site.

Authors:  A C Forster; R H Symons
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

2.  Design of allosteric hammerhead ribozymes activated by ligand-induced structure stabilization.

Authors:  G A Soukup; R R Breaker
Journal:  Structure       Date:  1999-07-15       Impact factor: 5.006

3.  Competitive regulation of modular allosteric aptazymes by a small molecule and oligonucleotide effector.

Authors:  S Hani Najafi-Shoushtari; Michael Famulok
Journal:  RNA       Date:  2005-10       Impact factor: 4.942

4.  Engineered allosteric ribozymes that sense the bacterial second messenger cyclic diguanosyl 5'-monophosphate.

Authors:  Hongzhou Gu; Kazuhiro Furukawa; Ronald R Breaker
Journal:  Anal Chem       Date:  2012-05-21       Impact factor: 6.986

5.  Kinetics of intermolecular cleavage by hammerhead ribozymes.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

6.  Structural basis of ligand binding by a c-di-GMP riboswitch.

Authors:  Kathryn D Smith; Sarah V Lipchock; Tyler D Ames; Jimin Wang; Ronald R Breaker; Scott A Strobel
Journal:  Nat Struct Mol Biol       Date:  2009-11-08       Impact factor: 15.369

7.  Riboswitches in eubacteria sense the second messenger cyclic di-GMP.

Authors:  N Sudarsan; E R Lee; Z Weinberg; R H Moy; J N Kim; K H Link; R R Breaker
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

8.  Artificial ribozyme switches containing natural riboswitch aptamer domains.

Authors:  Markus Wieland; Armin Benz; Benedikt Klauser; Jörg S Hartig
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

9.  An allosteric self-splicing ribozyme triggered by a bacterial second messenger.

Authors:  Elaine R Lee; Jenny L Baker; Zasha Weinberg; Narasimhan Sudarsan; Ronald R Breaker
Journal:  Science       Date:  2010-08-13       Impact factor: 47.728

10.  Recognition of the bacterial second messenger cyclic diguanylate by its cognate riboswitch.

Authors:  Nadia Kulshina; Nathan J Baird; Adrian R Ferré-D'Amaré
Journal:  Nat Struct Mol Biol       Date:  2009-11-08       Impact factor: 15.369

View more
  4 in total

1.  A convolutional neural network for the prediction and forward design of ribozyme-based gene-control elements.

Authors:  Calvin M Schmidt; Christina D Smolke
Journal:  Elife       Date:  2021-04-16       Impact factor: 8.140

Review 2.  Intracellular Imaging with Genetically Encoded RNA-based Molecular Sensors.

Authors:  Zhining Sun; Tony Nguyen; Kathleen McAuliffe; Mingxu You
Journal:  Nanomaterials (Basel)       Date:  2019-02-08       Impact factor: 5.076

3.  Integration of an Expression Platform in the SELEX Cycle to Select DNA Aptamer Binding to a Disease Biomarker.

Authors:  Yaqi Ao; Anqi Duan; Binfen Chen; Xinmei Yu; Yaoyao Wu; Xiaojun Zhang; Sanshu Li
Journal:  ACS Omega       Date:  2022-03-17

Review 4.  Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors.

Authors:  Zachary J Tickner; Michael Farzan
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.